← Open Payments lookup

CAROL OW: Open Payments

NPI 1609307016 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,749 in 72 payments from 11 companies in 2025. Trend: 2023 $349 · 2024 $2,192 · 2025 $1,749

Food & beverage: $1,650Education: $99
CompanyPaymentsAmount
ABBVIE INC.20$393
Ardelyx, Inc.11$284
QOL Medical, LLC9$241
Madrigal Pharmaceuticals9$224
Janssen Biotech, Inc.6$214
Novo Nordisk Inc4$121
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$92
Phathom Pharmaceuticals, Inc.4$84
Celltrion USA Inc.2$36
Braintree Laboratories, Inc.2$35

Products named: IBSRELA, Sucraid, REZDIFFRA, TREMFYA, RINVOQ, Wegovy, XIFAXAN, LINZESS.

Industry payments across CA — which companies pay providers there.